Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Cited In for PubMed (Select 6991948)

1.

Recent advances in the entirely subcutaneous ICD System.

Bettin M, Reinke F, Rath B, Köbe J, Eckardt L.

F1000Prime Rep. 2015 Apr 2;7:46. doi: 10.12703/P7-46. eCollection 2015. Review.

2.
3.

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.

Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kääb S, Murgatroyd F, Reeve HL, Carter N, Boersma L; EFFORTLESS Investigators.

Eur Heart J. 2014 Jul 1;35(25):1657-65. doi: 10.1093/eurheartj/ehu112. Epub 2014 Mar 26.

4.

Sudden cardiac death--historical perspectives.

Abhilash SP, Namboodiri N.

Indian Heart J. 2014 Jan-Feb;66 Suppl 1:S4-9. doi: 10.1016/j.ihj.2014.01.002. Epub 2014 Feb 11. Review.

5.

Cost-effectiveness of implantable cardioverter-defibrillator in today's world.

Boriani G, Cimaglia P, Biffi M, Martignani C, Ziacchi M, Valzania C, Diemberger I.

Indian Heart J. 2014 Jan-Feb;66 Suppl 1:S101-4. doi: 10.1016/j.ihj.2013.12.034. Epub 2013 Dec 31. Review.

6.

Evaluation of acute cardiac and chest wall damage after shocks with a subcutaneous implantable cardioverter defibrillator in Swine.

Killingsworth CR, Melnick SB, Litovsky SH, Ideker RE, Walcott GP.

Pacing Clin Electrophysiol. 2013 Oct;36(10):1265-72. doi: 10.1111/pace.12173. Epub 2013 May 28.

7.

Shock or no shock - a question of philosophy or should intraoperative implantable cardioverter defibrillator testing be recommended?

Keyser A, Hilker MK, Schmidt S, von Bary C, Zink W, Ried M, Schmid C, Diez C.

Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):321-5. doi: 10.1093/icvts/ivs479. Epub 2012 Dec 7.

8.

Critical appraisal of cardiac implantable electronic devices: complications and management.

Padeletti L, Mascioli G, Perini AP, Grifoni G, Perrotta L, Marchese P, Bontempi L, Curnis A.

Med Devices (Auckl). 2011;4:157-67. doi: 10.2147/MDER.S15059. Epub 2011 Sep 9.

9.

Implantable cardioverter-defibrillators: indications and unresolved issues.

Kedia R, Saeed M.

Tex Heart Inst J. 2012;39(3):335-41. Review.

10.

The rise of cardiovascular medicine.

Braunwald E.

Eur Heart J. 2012 Apr;33(7):838-45, 845a. doi: 10.1093/eurheartj/ehr452. Epub 2012 Mar 12.

11.

Changing nature of cardiac interventions in older adults.

Dodson JA, Maurer MS.

Aging health. 2011 Apr;7(2):283-295.

12.

Challenging cardiac electrophysiology.

Coronel R.

Front Physiol. 2010 May 28;1:8. doi: 10.3389/fphys.2010.00008. eCollection 2010. No abstract available.

13.

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy.

van Welsenes GH, Borleffs CJ, van Rees JB, Atary JZ, Thijssen J, van der Wall EE, Schalij MJ.

Neth Heart J. 2011 Jan;19(1):24-30. Epub 2010 Dec 22.

14.

The dawn of a new era in the struggle against sudden cardiac death.

Hauer RN.

Neth Heart J. 2009 Mar;17(3):111-2. No abstract available.

15.

Chronaxie of defibrillation: a pathway toward further optimization of defibrillation waveform?

Efimov IR.

J Cardiovasc Electrophysiol. 2009 Mar;20(3):315-7. doi: 10.1111/j.1540-8167.2008.01330.x. Epub 2008 Oct 14. No abstract available.

16.

Perioperative management of patients with implantable cardioverter defibrillators.

Donnelly P, Pal N, Herity NA.

Ulster Med J. 2007 May;76(2):66-7. No abstract available.

17.

Risk stratification for sudden cardiac death in patients with non-ischemic dilated cardiomyopathy.

Shekha K, Ghosh J, Thekkoott D, Greenberg Y.

Indian Pacing Electrophysiol J. 2005 Apr 1;5(2):122-38.

18.

The use of implantable cardioverter defibrillators in Iceland: a retrospective population based study.

Leosdottir M, Reimarsdottir G, Gottskalksson G, Torfason B, Vigfusdottir M, Arnar DO.

BMC Cardiovasc Disord. 2006 May 24;6:22.

19.

The implantable cardioverter-defibrillator: postcode prescribing in the UK 1998-2002.

Cunningham AD, Plummer CJ, McComb JM, Lord SW, Cunningham MW, Toussaint JM, Rickards AF.

Heart. 2005 Oct;91(10):1280-3. Epub 2005 Mar 29.

20.

The MADIT II and COMPANION studies: will they affect uptake of device treatment?

Morgan JM.

Heart. 2004 Mar;90(3):243-5. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk